Grant: Canada Postdoctoral Research Award (CPRA) program
McGill University
$140,000.00
Unravelling the impact of AMPA receptor missense mutations in neurodevelopmental disorders
EF 2025-26
Résumé
Almost 100 million people worldwide or 1-2 % of the global population have been estimated to be affected by intellectual disability (ID). ID is a condition that is often first detected during early childhood and is characterized by significant challenges in both intellectual functioning, such as learning, reasoning and problem solving, as well as adaptive behaviors, such as language, literacy and social skills. ID is also associated with other neurological deficits including autism, seizures, attention deficit, cerebral palsy, vision and hearing deficiencies. Despite this level of understanding, there is still no cure or effective clinical treatment for ID. Emerging evidence, however, increasingly identifies ID as a disorder associated with disrupted neurochemical communication between nerve cells in the brain mediated by the excitatory neurotransmitter, L-glutamic acid (L-Glu).
In this application, I will study the impact of missense mutations found in the genes of patients with ID that encode the AMPA receptor (AMPAR), which is an abundantly expressed neurotransmitter receptor activated by L-Glu. Since AMPARs mediate almost all fast excitatory signaling in neuronal circuits, deficits in their function would be expected to have detrimental effects on the developing and adult brain. The proposed experiments will uncover how missense mutations disrupt AMPAR function and thus will offer an entirely new insight into the molecular origins of ID. Furthermore, information gleaned from my work will provide a valuable framework to develop clinical strategies for the potential treatment of ID in the future.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
536851
Name
Wang Xin-Tong
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Unravelling the impact of AMPA receptor missense mutations in neurodevelopmental disorders
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Ampa Receptors; Cryogenic Electron Microscopy (Cryo-Em); Electrophysiology; Glutamatergic Neurotransmission; Intellectual Disability; Ion Channel Biophysics; Missense Mutations; Modal Gating Behavior; Neurodevelopmental Disorders; Structure
Abstract
Almost 100 million people worldwide or 1-2 % of the global population have been estimated to be affected by intellectual disability (ID). ID is a condition that is often first detected during early childhood and is characterized by significant challenges in both intellectual functioning, such as learning, reasoning and problem solving, as well as adaptive behaviors, such as language, literacy and social skills. ID is also associated with other neurological deficits including autism, seizures, attention deficit, cerebral palsy, vision and hearing deficiencies. Despite this level of understanding, there is still no cure or effective clinical treatment for ID. Emerging evidence, however, increasingly identifies ID as a disorder associated with disrupted neurochemical communication between nerve cells in the brain mediated by the excitatory neurotransmitter, L-glutamic acid (L-Glu).
In this application, I will study the impact of missense mutations found in the genes of patients with ID that encode the AMPA receptor (AMPAR), which is an abundantly expressed neurotransmitter receptor activated by L-Glu. Since AMPARs mediate almost all fast excitatory signaling in neuronal circuits, deficits in their function would be expected to have detrimental effects on the developing and adult brain. The proposed experiments will uncover how missense mutations disrupt AMPAR function and thus will offer an entirely new insight into the molecular origins of ID. Furthermore, information gleaned from my work will provide a valuable framework to develop clinical strategies for the potential treatment of ID in the future.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Wang, Xin-Tong
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~